Table 2 Characteristics of Included Studies
Study | TN | Age(C/B,yeas) (Median, range) | Number (C/B) | Male(C/B) | SM(C/B) | Primary Tumor Site(C/B) | Metastatic cancer in one Site(C/B) |
|---|---|---|---|---|---|---|---|
Venook AP 2017 | 1137 | 59.2 (20.8–89.5)/59.0 (21.8–85.0) | 578/559 | 349/348 | 447/445 | Ri:138,L:355,T:31,T:1,Un:53/Ri:142,L:34,T:31,T:0,Un:52 | 187/165(liver only) |
FIRE-3 | 592 | <65y:158/160;>65y:139/135 | 297/295 | 214/196 | Un | Co:168,Re:115/Co:177,Re:106 | 119/123 |
Houts AC 2017 | 400 | 61.8 ± 12.65/61.7 ± 11.77 | 146/254 | 93/140 | 73/167 | Ri:43,L:92,Un:11/Ri:79,L:162,Un:13 | Un |
2016 Bai L | 289 | 55 (21–83)/50 (24–79) | 101/188 | 68/120 | Un | Co:65,Re:36/ Co:116,Re:70 | 64/106 |
2014 Yang YH | 158 | <60Y:38/43; >60Y:25/52 | 63/95 | 34/63 | Un | Co:49,Re:14/ Co:72,Re:23 | Un |